Blog & News
Patient Reported Outcomes in Clinical Practice
Learn how to use Patient Reported Outcomes in Clinical Practice in the webinar replay; Applications, challenges & guidelines.
Discrete Choice Experiments for Market Access
What is Market Access? When learning how to use Discrete Choice Experiments, first we have to look at the bigger picture. Market Access focuses on enabling patients to access treatments beneficial to their health. When a treatment finally survived the long and tedious...
ATMPs & Patient Awareness
Webinar ATMPs & Patient AwarenessLearn about patient's awareness for ATMPs and challenges in evidence generation. Our experts discuss the most recent evidence on patient's and public perspectives, barriers to engagement and evaluation of patients' experience....
Isheo Bulletin – Epidermolysis Bullosa
Insights on the importance of understanding and researching the unmet medical needs for patients with Epidermolysis Bullosa.
Evidence Synthesis in the EU
In this webinar, ISHEO and AREX Advisor focused on presenting an overview of how different EU countries apply Evidence Synthesis to provide a compass and help professionals navigate the sea of ​​uncertainty created by the vast set of studies present today. Together,...
What are Patient Reported Outcomes
During the last webinar, 'Patient-Reported Outcomes' organized by ISHEO into its Access matters webinar series, Davide Integlia, CEO of ISHEO, interviews Linda Abet Webb, CEO of P-COA, focusing on how Patient-Reported Outcomes are becoming increasingly crucial for...
Market Access in Italy
Are you looking to launch a new drug in Italy? When deciding to enter Italy, realise that there not a single health system but many small health systems, each requiring a detailed market entry strategy.